Terms: = Germ cell tumor AND PIM1, PIM, 5292, ENSG00000137193, P11309
42 results:
1. DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma.
Ma S; Pan X; Gan J; Guo X; He J; Hu H; Wang Y; Ning S; Zhi H
Epigenetics; 2024 Dec; 19(1):2318506. PubMed ID: 38439715
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic protein kinase signalling in neuroblastoma.
Smiles WJ; Catalano L; Stefan VE; Weber DD; Kofler B
Mol Metab; 2023 Sep; 75():101771. PubMed ID: 37414143
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of pim Kinases Promotes Neuroblastoma cell Differentiation to a Neuronal Phenotype.
Julson JR; Quinn CH; Bownes LV; Hutchins SC; Stewart JE; Aye J; Yoon KJ; Beierle EA
J Pediatr Surg; 2023 Jun; 58(6):1155-1163. PubMed ID: 36907773
[TBL] [Abstract] [Full Text] [Related]
4. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma.
Li X; Moreira DC; Bag AK; Qaddoumi I; Acharya S; Chiang J
Neuro Oncol; 2023 Apr; 25(4):750-760. PubMed ID: 36260562
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDH
Wang S; Li L; Zuo S; Kong L; Wei J; Dong J
Front Immunol; 2022; 13():869061. PubMed ID: 36248907
[TBL] [Abstract] [Full Text] [Related]
6. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
7. Melatonin Inhibits the Malignant Progression of Glioblastoma via Regulating miR-16-5p/pim1.
Yan Z; Zhang X; Hua L; Huang L
Curr Neurovasc Res; 2022; 19(1):92-99. PubMed ID: 35388757
[TBL] [Abstract] [Full Text] [Related]
8. Quercetin increases mitochondrial proteins (VDAC and SDH) and downmodulates AXL and pim-1 tyrosine kinase receptors in NRAS melanoma cells.
Rocha-Brito KJP; Clerici SP; Cordeiro HG; Scotá Ferreira AP; Barreto Fonseca EM; Gonçalves PR; Abrantes JLF; Milani R; Massaro RR; Maria-Engler SS; Ferreira-Halder CV
Biol Chem; 2022 Feb; 403(3):293-303. PubMed ID: 34854272
[TBL] [Abstract] [Full Text] [Related]
9. pim1 Inhibition Affects Glioblastoma Stem cell Behavior and Kills Glioblastoma Stem-like cells.
Seifert C; Balz E; Herzog S; Korolev A; Gaßmann S; Paland H; Fink MA; Grube M; Marx S; Jedlitschky G; Tzvetkov MV; Rauch BH; Schroeder HWS; Bien-Möller S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681783
[TBL] [Abstract] [Full Text] [Related]
10. Identification of pimavanserin tartrate as a potent Ca
Liu ZZ; Liu XN; Fan RC; Jia YP; Zhang QK; Gao XQ; Wang YQ; Yang MQ; Ji LZ; Zhou YQ; Li HL; Li P; Tang B
Acta Pharmacol Sin; 2021 Nov; 42(11):1860-1874. PubMed ID: 34363007
[TBL] [Abstract] [Full Text] [Related]
11. Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances cell Growth by Retrieving pim1 From miR-761.
Wang W; Han S; Gao W; Feng Y; Li K; Wu D
Cell Mol Neurobiol; 2022 Apr; 42(3):695-708. PubMed ID: 32897512
[TBL] [Abstract] [Full Text] [Related]
12. High Expression of NEK2 and pim1, but Not pim3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.
Motylewska E; Braun M; Stępień H
Endocr Pathol; 2020 Sep; 31(3):264-273. PubMed ID: 32504181
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced Anti-melanoma Efficacy of a pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic cells.
Liu J; Hu Y; Guo Q; Yu X; Shao L; Zhang C
Front Immunol; 2019; 10():2721. PubMed ID: 31849942
[TBL] [Abstract] [Full Text] [Related]
14. The targetable kinase pim1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.
Trigg RM; Lee LC; Prokoph N; Jahangiri L; Reynolds CP; Amos Burke GA; Probst NA; Han M; Matthews JD; Lim HK; Manners E; Martinez S; Pastor J; Blanco-Aparicio C; Merkel O; de Los Fayos Alonso IG; Kodajova P; Tangermann S; Högler S; Luo J; Kenner L; Turner SD
Nat Commun; 2019 Nov; 10(1):5428. PubMed ID: 31780656
[TBL] [Abstract] [Full Text] [Related]
15. Anti-tumor effects of pim/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
Mohlin S; Hansson K; Radke K; Martinez S; Blanco-Apiricio C; Garcia-Ruiz C; Welinder C; Esfandyari J; O'Neill M; Pastor J; von Stedingk K; Bexell D
EMBO Mol Med; 2019 Aug; 11(8):e10058. PubMed ID: 31310053
[TBL] [Abstract] [Full Text] [Related]
16. Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities.
Coppé JP; Mori M; Pan B; Yau C; Wolf DM; Ruiz-Saenz A; Brunen D; Prahallad A; Cornelissen-Steijger P; Kemper K; Posch C; Wang C; Dreyer CA; Krijgsman O; Lee PRE; Chen Z; Peeper DS; Moasser MM; Bernards R; van 't Veer LJ
Nat Cell Biol; 2019 Jun; 21(6):778-790. PubMed ID: 31160710
[TBL] [Abstract] [Full Text] [Related]
17. pim kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.
Serrano-Saenz S; Palacios C; Delgado-Bellido D; López-Jiménez L; Garcia-Diaz A; Soto-Serrano Y; Casal JI; Bartolomé RA; Fernández-Luna JL; López-Rivas A; Oliver FJ
Cell Death Dis; 2019 Jan; 10(2):51. PubMed ID: 30718520
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of pim1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis.
Remy J; Linder B; Weirauch U; Konovalova J; Marschalek R; Aigner A; Kögel D
Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):175-189. PubMed ID: 30389373
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine tumors.
Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
[TBL] [Abstract] [Full Text] [Related]
20. pim Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma.
Brunen D; de Vries RC; Lieftink C; Beijersbergen RL; Bernards R
Mol Cancer Ther; 2018 Apr; 17(4):849-857. PubMed ID: 29440296
[TBL] [Abstract] [Full Text] [Related]
[Next]
